The aim of the current study was to evaluate the expression of cyclins A2, B1, D1, and E1 and CCND1 gene status in a single cohort of patients with oral squamous cell carcinomas (OSCC) and relate them to clinical-pathologic characteristics and patient outcome. The gene discussed is CCNA2; the disease is oral cavity squamous cell carcinoma.